COMBINATION TREATMENT FOR CANCER BASED UPON AN ICOS ANTIBODY AND A PD-L1 ANTIBODY TGF-BETA-RECEPTOR FUSION PROTEIN
Publication
EP4136105A1
Kind: A1
Mar 18, 2026
Applicants
GlaxoSmithKline Intellectual Property Development Limited, Ares Trading S.A.
Inventors
BALLAS, Marc S., ELLIS, Catherine E., HIRSCHFELD, Steven
IPC Classifications
C07K 14/71 20060101AFI20211022BHEP
C07K 16/28 20060101ALI20211022BHEP
A61K 39/395 20060101ALI20211022BHEP
A61P 35/00 20060101ALI20211022BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR